Anti-Vaccinia virus/VACV L4R/VP8 Polyclonal Antibody from ProteoGenix; catalogue ARO-A21932; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Vaccinia virus/VACV L4R/VP8 Polyclonal Antibody – the ultimate solution for your biotech research needs.
This highly specific antibody is designed to target the L4R/VP8 protein of the Vaccinia virus, making it a powerful tool for studying the virus and its effects. With its superior quality and proven effectiveness, our Anti-Vaccinia virus/VACV L4R/VP8 Polyclonal Antibody is a must-have for any biotech laboratory.
The Vaccinia virus is a large, complex virus that is known to cause infections in humans and animals. The L4R/VP8 protein is a key component of the virus, playing a crucial role in its replication and spread within the host. Our Anti-Vaccinia virus/VACV L4R/VP8 Polyclonal Antibody specifically binds to this protein, inhibiting its function and preventing the virus from replicating.
This antibody is ideal for a wide range of applications, including virus detection, diagnosis, and vaccine development. It can also be used for studying the mechanism of action of the Vaccinia virus and its interactions with host cells. Additionally, it can be used in various immunoassays, such as ELISA and Western blot, to detect the presence of the virus.
Our Anti-Vaccinia virus/VACV L4R/VP8 Polyclonal Antibody has been extensively tested and validated in various experimental settings. It has shown excellent results in neutralizing the virus in cell culture and animal models, making it a valuable tool for in vitro and in vivo studies. Moreover, it has been successfully used in diagnostic assays to detect the presence of the virus in clinical samples.
With its high specificity and sensitivity, our Anti-Vaccinia virus/VACV L4R/VP8 Polyclonal Antibody is a top choice for researchers working on Vaccinia virus-related projects. Its easy-to-use format and reliable results make it a cost-effective solution for any laboratory. Order now and take your biotech research to the next level!
Keywords: Anti-Vaccinia virus, VACV L4R/VP8 Polyclonal Antibody, biotech research, virus detection, diagnosis, vaccine development, immunoassays, ELISA, Western blot, neutralization, cell culture, animal models, diagnostic assays, clinical samples, specificity, sensitivity, cost-effective, laboratory.
ProteoGenix catalogue number ARO-A21932. For research use only.
Target: L4R/VP8; Clonality: Polyclonal Antibody; Applications: IHC, ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| L4R/VP8 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
